{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:30:30Z","timestamp":1793820630365,"version":"4.6.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jss.2023.11.073","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T11:13:30Z","timestamp":1703502810000},"page":"753-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Eukaryotic Translation Initiation Factor 2 Subunit \u03b2 as a Prognostic Biomarker Associates With Immune Cell Infiltration in Breast Cancer"],"prefix":"10.1016","volume":"295","author":[{"given":"Mengmeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2023.11.073_bib1","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2023.11.073_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2023.11.073_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2023.11.073_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2023.11.073_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature16991","article-title":"Crystal structure of eukaryotic translation initiation factor 2B","volume":"531","author":"Kashiwagi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jss.2023.11.073_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2020.02.004","article-title":"RBP EIF2S2 promotes tumorigenesis and progression by regulating MYC-mediated inhibition via FHIT-related enhancers","volume":"28","author":"Zhang","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jss.2023.11.073_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/cas.13602","article-title":"eIF2beta, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer","volume":"109","author":"Tanaka","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jss.2023.11.073_bib8","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jss.2023.11.073_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumor heterogeneity and tumor cell plasticity during malignant progression","volume":"125","author":"L\u00fc\u00f6nd","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2023.11.073_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48570-x","article-title":"Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series","volume":"9","author":"Vallon-Christersson","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2023.11.073_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/cells9030760","article-title":"Transcription factors in cancer: when alternative splicing determines Opposite cell fates","volume":"9","author":"Belluti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jss.2023.11.073_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbagrm.2014.12.007","article-title":"Roles of the translation initiation factor eIF2\u03b1 serine 51 phosphorylation in cancer formation and treatment","volume":"1849","author":"Koromilas","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jss.2023.11.073_bib13","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.7150\/jca.57926","article-title":"18F-FDG PET\/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer","volume":"12","author":"Yang","year":"2012","journal-title":"J Cancer"},{"key":"10.1016\/j.jss.2023.11.073_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.856974","article-title":"Breast cancer stem-like cells in drug resistance: a review of mechanisms and novel therapeutic strategies to overcome drug resistance","volume":"12","author":"Saha","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2023.11.073_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2023.11.073_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-020-04222-w","article-title":"Tumor microenvironment promotes breast cancer chemoresistance","volume":"87","author":"Mehraj","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2023.11.073_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple-negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jss.2023.11.073_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000169","article-title":"Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer","volume":"8","author":"Bai","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jss.2023.11.073_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","article-title":"The PI3K\/Akt\/GSK-3beta\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility","volume":"16","author":"Jin","year":"2019","journal-title":"Cancer Biol Med"}],"updated-by":[{"DOI":"10.1016\/j.jss.2024.04.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423006455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423006455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:11:16Z","timestamp":1793819476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480423006455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"alternative-id":["S0022480423006455"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2023.11.073","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eukaryotic Translation Initiation Factor 2 Subunit \u03b2 as a Prognostic Biomarker Associates With Immune Cell Infiltration in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2023.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}